These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 28622910)
21. Complement system and age-related macular degeneration: drugs and challenges. Wu J; Sun X Drug Des Devel Ther; 2019; 13():2413-2425. PubMed ID: 31409975 [TBL] [Abstract][Full Text] [Related]
22. Neuromyelitis optica-like pathology is dependent on type I interferon response. Khorooshi R; Wlodarczyk A; Asgari N; Owens T Exp Neurol; 2013 Sep; 247():744-7. PubMed ID: 23434493 [TBL] [Abstract][Full Text] [Related]
23. Complement activation in patients with neuromyelitis optica. Nytrova P; Potlukova E; Kemlink D; Woodhall M; Horakova D; Waters P; Havrdova E; Zivorova D; Vincent A; Trendelenburg M J Neuroimmunol; 2014 Sep; 274(1-2):185-91. PubMed ID: 25109258 [TBL] [Abstract][Full Text] [Related]
24. Complement and immune defense: from innate immunity to human diseases. Zipfel PF Immunol Lett; 2009 Sep; 126(1-2):1-7. PubMed ID: 19616581 [TBL] [Abstract][Full Text] [Related]
25. Complement activation as a biomarker for Alzheimer's disease. Aiyaz M; Lupton MK; Proitsi P; Powell JF; Lovestone S Immunobiology; 2012 Feb; 217(2):204-15. PubMed ID: 21856034 [TBL] [Abstract][Full Text] [Related]
26. The role of the complement system in innate immunity. Rus H; Cudrici C; Niculescu F Immunol Res; 2005; 33(2):103-12. PubMed ID: 16234578 [TBL] [Abstract][Full Text] [Related]
27. The spectrum of neuromyelitis optica. Wingerchuk DM; Lennon VA; Lucchinetti CF; Pittock SJ; Weinshenker BG Lancet Neurol; 2007 Sep; 6(9):805-15. PubMed ID: 17706564 [TBL] [Abstract][Full Text] [Related]
29. The complement system in inflammatory bowel disease. Jain U; Otley AR; Van Limbergen J; Stadnyk AW Inflamm Bowel Dis; 2014 Sep; 20(9):1628-37. PubMed ID: 24831561 [TBL] [Abstract][Full Text] [Related]
30. Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation. Ratay ML; Bellotti E; Gottardi R; Little SR Adv Healthc Mater; 2017 Dec; 6(23):. PubMed ID: 29034584 [TBL] [Abstract][Full Text] [Related]
31. Complement in multiple sclerosis: its role in disease and potential as a biomarker. Ingram G; Hakobyan S; Robertson NP; Morgan BP Clin Exp Immunol; 2009 Feb; 155(2):128-39. PubMed ID: 19040603 [TBL] [Abstract][Full Text] [Related]
32. Intracellular complement - the complosome - in immune cell regulation. Arbore G; Kemper C; Kolev M Mol Immunol; 2017 Sep; 89():2-9. PubMed ID: 28601357 [TBL] [Abstract][Full Text] [Related]
33. The Challenges and Promise of Complement Therapeutics for Ocular Diseases. Park DH; Connor KM; Lambris JD Front Immunol; 2019; 10():1007. PubMed ID: 31156618 [TBL] [Abstract][Full Text] [Related]
34. The complement system in ocular allergy. Mondino BJ; Phinney R Int Ophthalmol Clin; 1988; 28(4):329-31. PubMed ID: 3053494 [No Abstract] [Full Text] [Related]
35. Complement involvement in neovascular ocular diseases. Yanai R; Thanos A; Connor KM Adv Exp Med Biol; 2012; 946():161-83. PubMed ID: 21948368 [TBL] [Abstract][Full Text] [Related]
37. A regulatory role for complement in innate immunity and autoimmunity. Nauta AJ; Roos A; Daha MR Int Arch Allergy Immunol; 2004 Aug; 134(4):310-23. PubMed ID: 15218334 [TBL] [Abstract][Full Text] [Related]
38. Novel mechanisms and functions of complement. Hajishengallis G; Reis ES; Mastellos DC; Ricklin D; Lambris JD Nat Immunol; 2017 Nov; 18(12):1288-1298. PubMed ID: 29144501 [TBL] [Abstract][Full Text] [Related]
39. The hijackers guide to escaping complement: Lessons learned from pathogens. Ermert D; Ram S; Laabei M Mol Immunol; 2019 Oct; 114():49-61. PubMed ID: 31336249 [TBL] [Abstract][Full Text] [Related]
40. A Family Affair: Addressing the Challenges of Factor H and the Related Proteins. Poppelaars F; Goicoechea de Jorge E; Jongerius I; Baeumner AJ; Steiner MS; Józsi M; Toonen EJM; Pauly D; Front Immunol; 2021; 12():660194. PubMed ID: 33868311 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]